Prostate cancer drug targeting Achilles heel approved in Europe 06 Nov 2020 The Institute of Cancer Research, London, has strongly welcomed the approval by the European Commission of the targeted drug olaparib for men with advanced prostate cancers with genetic alterations in BRCA1 or BRCA2. Find out more Show/Hide
ICR is top-ranked university for invention income for seventh consecutive year 21 Oct 2020 The Institute of Cancer Research, London, has again been the most successful academic institution in the UK at making income from its intellectual property – for the seventh successive year. Find out more Show/Hide
Aggressive childhood cancer could be treated by combining DNA-damage targeting drugs 29 Sep 2020 An aggressive form of the childhood cancer neuroblastoma could be treatable with two cancer drugs currently used in the treatment of colon and ovarian cancer, a study led by researchers at The Institute of Cancer Research, London, suggests. Find out more Show/Hide
ESMO 2020: Step forward in treatment for patients with newly diagnosed advanced ovarian cancer 18 Sep 2020
Drug used in breast and ovarian cancer could lead to safer, more effective treatment for neuroblastoma 25 Jun 2020
ICR research showcased in major new Science Museum gallery documenting history of medicine 29 Jan 2020